News
Home  >  News > La Marató 2020 promotes UB research projects to fight COVID-19

La Marató 2020 promotes UB research projects to fight COVID-19

La crida solidària de La Marató tornarà a impulsar projectes de recerca de la UB distingits en la lluita contra la COVID-19.

La crida solidària de La Marató tornarà a impulsar projectes de recerca de la UB distingits en la lluita contra la COVID-19.

La Marató destinarà prop de 14 milions d’euros a finançar 36 projectes d’investigació biomèdica d’excel·lència.

La Marató destinarà prop de 14 milions d’euros a finançar 36 projectes d’investigació biomèdica d’excel·lència.

14/06/2021

Recerca

La Marató de TV3 and Catalunya Ràdio in 2020, dedicated to COVID-19, will give 12.5 million euros to fund 36 excellence biomedical research projects to improve the quality and life expectancy of people affected by SARS-CoV-2.

The 2020 edition received 229 projects, assessed by ninety-five scientists from international fields, experts on this issue. The assessment criteria were quality, methodology and relevance of the proposals. The management of such assessment was carried out by the Agency for Health Quality and Assessment of Catalonia, from the Department of Health of the Catalan Government.

Like in previous editions, La Marató’s call will promote awarded UB research projects to fight COVID-19

Awarded projects in La Marató 2020 linked to the University of Barcelona

“Assessment of COVID-19 outbreak through wastewater epidemiology: typing, community screening and occupational risk

Sílvia Bofill Mas, Faculty of Biology (University of Barcelona); Lluís Corominas Tabares, Water Research Institute Foundation (ICRA); Núria Canela Canela, Eurecat Foundation and Technological Centre of Catalonia (Eurecat)

Funding: 379,100.00 €



“Impact of Maternal COVID-19 Disease on Breast Milk and Infant Health (MilkCorona)”

F Francisco José Pérez Cano, Faculty of Pharmacy and Food Sciences (University of Barcelona); Carmen Collado Amores, Institute of Agrochemistry and Food Technology (CSIC); Carles Lerín Martínez, Instiute for Research and Teaching Sant Joan de Déu Private Foundation

Funding: 354,375.00 €
“Diagnosis and treatment for Sars-CoV-2 by triplex formation”

Verónica Noé Mata, Bosch i Gimpera Foundation and Faculty of Pharmacy and Food Sciences (University of Barcelona); Ramon Eritja Casadellà, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC); Enrique Calderón Sandubete, Andalusian Public Foundation for the Management of Health Researh in Sevilla University Hospital Virgen del Rocío; María Valeria Grazú Bonavía, Institute of Nanosciences and Materials in Aragon (CSIC)

Funding: 398,750.00 €

“Cognition, emotion/behaviour, brain functionality and connectivity in recovered COVID-19 patients (NAUTILUS)”

Bàrbara Segura Fàbregas, Faculty of Medicine and Health Sciences (University of Barcelona); Maite Garolera Freixa, Joan Costa Roma Hospital de Terrassa Foundation; Claudio Ulises Cortés Garcia, Technical University of Catalonia

Funding: 399,268.75 €


“Characterization and modulation of neural networks to promote resilience to COVID-19 pandemic”

David Bartrés Faz, Faculty of Medicine and Health Sciences (University of Barcelona); Álvaro Pascual-Leone García, Guttmann Institute Neurorehabilitation Hospital Foundation

Funding: 296,355.00 €

“A new therapeutical concept of pancoronavirus antiviral to fight present and future infections: degradation aimed at the viral protease 3CLpro”

Santiago Vázquez Cruz, Bosch i Gimpera Foundation and Faculty of Pharmacy and Food Sciences (University of Barcelona); Lieve Naesens, Catholic University of Leuven.

Funding: 300,000.00 €

Other projects related to the UB research environment:

 

“Security and immunogenicity of the ARNm SARS-CoV-2 vaccine in solid organ transplant receptors: multicenter study”

Marta Bodro Marimont, August Pi i Sunyer Biomedical Research Institute Consortium, IDIBAPS and Hospital Clínic de Barcelona; Marta Crespo Barrio, Hospital del Mar Biomedical Research Instiute (IMIM); Sònia Mirabet Pérez, Hospital de la Santa Creu i Sant Pau Research Institute (IRHSCSP) Funding: 230,545.00 €


“Reduction of the psychosocial impact of the COVID-19 pandemic in nursing home staff”

Josep Maria Haro Abad, Institute for Research and Teaching Sant Joan de Déu Private Foundation; Ellen Marïet Sijbrandij, Free University of Amsterdam; José Luis Ayuso Mateos, Faculty of Medicine of the Autonomous University of Madrid Funding: 309,920.00 €

“Understanding the role of human genetic variation and mediated phenocopies by antibodies in susceptibility to severe COVID-19”

Conxi Lázaro García, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology and IDIBELL; Xavier Corbella Virós, BellvitgeUniversity Hospital

Funding: 299,998.84 €

“Monitoring respiratory pattern of patients with severe COVID-19 pneumonia using a new non-invasive device”

Beatriz Giraldo Giraldo, Institute for Bionengineering of Catalonia (IBEC) Arantxa Mas Serra, Bellvitge Biomedical Research Institute (IDIBELL) and Integral Health Consortium (CSI)

Funding: 286,445.63 €

“Prediction of respiratory pronostic in patients with severe COVID-10 using metabolic signatures (CoRespirOmics)”

Santiago Marco Colás, Institute for Bioengineering of Catalonia (IBEC); Joan Ramon Masclans Enviz, Hospital del Mar Biomedical Research Institute (IMIM)

Funding: 295,750.00 €

“Composition of microbiota as a risk predictor in cancer patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection”

Víctor Raúl Moreno Aguado, Bellvitge Biomedical Research Instiute (IDIBELL) and Catalan Institute of Oncology (ICO); Paolo Nuciforo, Vall d’Hebron Institute on Oncology (VHIO)

Funding: 299,820.19 €

“Male reproductive function in COVID-19 patients”

Rafael Oliva Virgili, Clinic Foundation for Biomedical Research Foundation – Hospital Clínic de Barcelona (FCRB); Daniel Moreno Mendoza, Hospital de la Santa Creu i Sant Pau Research Institute and Puigvert Foundation (IRHSCSP); Melchor Carbonell Socias, Vall d’Hebron Research Institute (VHIR); Ignasi Roig Navarro, Autonomous University of Barcelona; Beatriz Candás Estébanez, Hospital de Barcelona and Healthcare Facilities Cooperative Society (SCIAS)
Funding: 399,821.25 €

“Efficiency and neurologic adverse effects of the vaccine against COVID-19 in immunoexpressed multiple sclerosis patients”

Albert Saiz Hinarejos, August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and Hospital Clínic de Barcelona; Thaís Armangué Salvador, Hospital Sant Joan de Déu Foundation for Research and Teaching; Luis Antonio Querol Gutiérrez, Hospital de la Santa Creu i Sant Pau Research Institute (IRHSCSP)

Funding: 397,442.50 €

“Interaction between ACE2 and AXL systems to predict the severity and results of COVID-19”

José Tomás Ortiz Pérez, August Pi i Sunyer Biomedical Research Instiute (IDIBAPS) and Hospital Clínic de Barcelona; María José Soler Romeo, Vall d’Hebron Research Institute (VHIR); Albert Morales Muñoz, Biomedical Research Institute of Barcelona (IIBB-CSIC)
Funding: 399,315.53 €

 

Share this at:
| More |
  • Follow us:
  • Button to access University of Barcelona's Facebook profile
  • Button to access University of Barcelona's Twitter profile
  • Button to access University of Barcelona's Instagram profile
  • Button to access University of Barcelona's Linkedin profile
  • Button to access University of Barcelona's Youtube profile
  • Button to access University of Barcelona's Google+ profile
  • ??? peu.flickr.alt ???
Member of International recognition of excellence HR Excellence in Research logo del leru - League of European Research Universities logo del bkc - campus excel·lència logo del health universitat de barcelona campus

© Universitat de Barcelona